In non-small cell lung cancers (NSCLC) it inhibits many tumor cell functions [29,30]; while a downregulation of SOCS3 was found in gastric adenocarcinoma tissues [31] and linked with enhanced risks of recurrent disease in BC patients [32]. Here, SOCS3 is linked to non-small cell lung carcinoma.